Spectral Genomics Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$14M
Spectral Genomics General Information
Description
Developer and marketer of products and services in molecular genetics and diagnostics. The company also provides genomic profiling services for customers in academic and industrial research laboratories.
Contact Information
Website
www.spectralgenomics.comCorporate Office
- 8080 North Stadium Drive
- Suite 2200
- Houston, TX 77054
- United States
Corporate Office
- 8080 North Stadium Drive
- Suite 2200
- Houston, TX 77054
- United States
Spectral Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 01-Apr-2006 | $14M | 000.00 | 0000 | Completed | Clinical Trials - Phase 3 |
| 4. Early Stage VC (Series B) | 15-Mar-2004 | 00.00 | 000.00 | Completed | Clinical Trials - Phase 3 | |
| 3. Early Stage VC (Series A) | 01-Aug-2001 | 000 | 000 | Completed | Startup | |
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Spin-Off | 01-Jan-2000 | Completed | Startup |
Spectral Genomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Spectral Genomics Patents
Spectral Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2004262040-A1 | Arrays, methods and kits for preparation and use of syntenic genomic arrays for diagnostics and toxicology | Inactive | 01-Aug-2003 | 0000000000 | |
| AU-2003220159-A8 | Articles of manufacture and methods for making hydrophobic derivatized arrays | Inactive | 08-Mar-2002 | 0000000000 | |
| AU-2003220159-A1 | Articles of manufacture and methods for making hydrophobic derivatized arrays | Inactive | 08-Mar-2002 | 0000000000 | |
| AU-2002357393-A1 | Methods for mapping the chromosomal loci of genes expressed by a cell | Inactive | 28-Dec-2001 | 0000000000 | |
| AU-2002365101-A1 | Articles of manufacture and methods for examining biochips using phase contrast optics | Inactive | 28-Dec-2001 | G02B21/14 |
Spectral Genomics Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BCM Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
| Baylor College Of Medicine | University | Minority | 000 0000 | 000000 0 |
| BioTex Finance | Venture Capital | Minority | 000 0000 | 000000 0 |
| Burrill & Co | Merchant Banking Firm | Minority | 000 0000 | 000000 0 |
| Houston Technology Center | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |
Spectral Genomics Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Bacterial BarCodes | 15-Mar-2004 | 0000000000 | Biotechnology | 000000 00 |
Spectral Genomics Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Bacterial BarCodes | 15-Mar-2004 | 000000000000 | Completed |
|
Spectral Genomics FAQs
-
When was Spectral Genomics founded?
Spectral Genomics was founded in 2000.
-
Where is Spectral Genomics headquartered?
Spectral Genomics is headquartered in Houston, TX.
-
What industry is Spectral Genomics in?
Spectral Genomics’s primary industry is Biotechnology.
-
Is Spectral Genomics a private or public company?
Spectral Genomics is a Private company.
-
What is the current valuation of Spectral Genomics?
The current valuation of Spectral Genomics is 0000.
-
What is Spectral Genomics’s current revenue?
The current revenue for Spectral Genomics is 000000.
-
How much funding has Spectral Genomics raised over time?
Spectral Genomics has raised $12.3M.
-
Who are Spectral Genomics’s investors?
BCM Ventures, Baylor College Of Medicine, BioTex Finance, Burrill & Co, and Houston Technology Center are 5 of 7 investors who have invested in Spectral Genomics.
-
When was Spectral Genomics acquired?
Spectral Genomics was acquired on 01-Apr-2006.
-
Who acquired Spectral Genomics?
Spectral Genomics was acquired by Revvity.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
